[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100627803":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":17,"responsibleParty":63,"collaborators":7,"id":65,"slug":7,"hasResults":66,"nctId":67,"briefTitle":68,"officialTitle":68,"acronym":7,"eligibilityCriteria":69,"healthyVolunteers":66,"sex":70,"minAge":71,"maxAge":7,"enrollmentInfo":72,"targetDuration":7,"studyType":75,"phases":7,"briefSummary":76,"conditions":77,"keywords":79,"overallStatus":85,"whyStopped":7,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"Peking University Third Hospital","OTHER",null,[9,14],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Ming Cui","CONTACT","010-82266699","mingcui@bjmu.edu.cn",{"name":15,"role":11,"phone":12,"phoneExt":7,"email":16},"Ruitao Zhang","clinicboy@126.com",[18,35,49],{"facility":19,"status":7,"city":20,"state":21,"zip":22,"country":23,"cosmosGeoPoint":24,"geoPoint":29,"contacts":30},"Wang Jing Hospital Of CACMS（China Academy of Chinese Medical Sciences）","Beijing","Beijing Municipality","100102","China",{"type":25,"coordinates":26},"Point",[27,28],116.39723,39.9075,{"lat":28,"lon":27},[31],{"name":32,"role":11,"phone":33,"phoneExt":7,"email":34},"Xiaojie chen","010-84739047","13810245800@163.com",{"facility":36,"status":7,"city":37,"state":38,"zip":7,"country":23,"cosmosGeoPoint":39,"geoPoint":43,"contacts":44},"Cangzhou Central Hospital","Cangzhou","Hebei",{"type":25,"coordinates":40},[41,42],116.85334,38.31124,{"lat":42,"lon":41},[45],{"name":46,"role":11,"phone":47,"phoneExt":7,"email":48},"Jun Zhang","0317-2075736","dr_zhangj@sina.com",{"facility":50,"status":7,"city":51,"state":52,"zip":7,"country":23,"cosmosGeoPoint":53,"geoPoint":57,"contacts":58},"Chengdu Second People's Hospital","Chengdu","Sichuan",{"type":25,"coordinates":54},[55,56],104.06667,30.66667,{"lat":56,"lon":55},[59],{"name":60,"role":11,"phone":61,"phoneExt":7,"email":62},"Jianxiong Liu","028-67830010","steven.ljx@vip.163.com",{"type":64,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100627803",false,"NCT07453381","Multisensor Wireless Pressure Microcatheter For Microvascular Function Assessment In ANOCA\u002FINOCA Patients: A Prospective, Multicenter, Single-Group Target Value Study","Inclusion Criteria:\n\n1. Age ≥ 18 years, gender not limited;\n2. Symptoms of angina pectoris, or objective evidence of myocardial ischemia (e.g., electrocardiogram, myocardial injury markers, etc.);\n3. Visual assessment of coronary angiography shows diameter stenosis \\\u003C 50% and FFR \\> 0.8 (or cRR \\> 0.89);\n4. Microvascular function assessment is planned;\n5. Agree to participate in this clinical study and voluntarily sign the informed consent form.\n\nExclusion Criteria:\n\n1. Acute myocardial infarction, PCI, CABG, or valvular surgery following angiography within the past 30 days;\n2. Severe valvular disease requiring surgical or interventional treatment;\n3. Chest pain with known non-ischemic causes (e.g., pericarditis, pulmonary hypertension, esophageal spasm);\n4. Contraindications to CMR (e.g., certain types of pacemakers or defibrillators, severe claustrophobia);\n5. Clear contraindications to adenosine and ATP use (e.g., second- or third-degree atrioventricular block, sick sinus syndrome, severe asthma, systolic blood pressure below 90 mmHg);\n6. Renal insufficiency (eGFR ≤ 45 mL\u002Fmin\u002F1.73 m2) or currently undergoing dialysis;\n7. Severe heart failure or LVEF ≤ 35%;\n8. Severe organ disease or life expectancy less than 2 years;\n9. Known to be participating in other drug or device clinical trials that have not yet met the primary endpoint;\n10. Other investigators deem the candidate unsuitable for this clinical trial.","ALL","18 Years",{"count":73,"type":74},114,"ESTIMATED","OBSERVATIONAL","This study aims to evaluate the sensitivity and specificity of a multi-sensor wireless pressure microcatheter for the diagnosis of CMD in patients with ANOCA\u002FINOCA, using quantitative myocardial perfusion imaging of cardiac magnetic resonance (CMR) as a reference.",[78],"Coronary Microvascular Dysfunction (CMD)",[80,81,82,83,84],"Pressure Microcatheter","Microvascular Function Assessment","Angina with Non-obstructive Coronary Arteries","Ischaemia with Non-obstructive Coronary Arteries","Coronary Microvascular Dysfunction","NOT_YET_RECRUITING","2026-03-01",{"date":88,"type":89},"2026-03-06","ACTUAL",{"date":91,"type":74},"2026-03-23",{"date":93,"type":74},"2026-10-31",{"name":5,"class":6},3]